Latest news
Search news stories
Enter a keyword to search news.
Daffodil Day
The Daffodil Day Appeal is Cancer Council’s most iconic and much-loved fundraising campaign. It is a day for Australians to give hope to those affected by all cancers by donating to support a cancer free future. This year, researchers at the DRMCRL volunteered in fund-raising activities across Adelaide to support the Cancer Council’s aim to raise more than $4 million for life-saving cancer research.
Mother’s Day Classic – National Breast Cancer Foundation’s (NBCF) annual fund raiser
Every single day, 50 women are diagnosed with breast cancer in Australia. University of Adelaide researchers at the DRMCRL work on research programs to improve disease outcomes by deeply understanding the role of sex hormones in tumour behaviour. Their research will be used to develop new drugs and treatments.
Dr Luke Selth – inaugural Rob Sutherland Award recipient
Dr Luke Selth from the DRMCRL was the inaugural Rob Sutherland Award recipient at\ this year’s PacRim meeting. This award, presented to an outstanding early/mid-career researcher, was the awarded by Rob Sutherland’s daughter and wife, Sarah and Cheryl Sutherland, at the PacRim Meeting Big Bash conference dinner at Seppeltsfield on last evening of the meeting.
[Read more about Dr Luke Selth – inaugural Rob Sutherland Award recipient ]
Dr Luke Selth inaugural recipient of the Rob Sutherland Award at 7th International PacRim Breast & Prostate Cancer Meeting
Congratulations to Dr Luke Selth as the recipient of the inaugural Rob Sutherland Award at this meeting. Dr Selth presented his research work on “The epigenetic and transcriptional landscape of neuroendocrine prostate cancer”.
Professor Wayne Tilley co-convenes 7th International PacRim Breast and Prostate Cancer Meeting
The PacRim Meeting series is a highly regarded think-tank meeting that focuses on breast and prostate cancer research. The 7th meeting in this series commenced on Sunday 17 March and a theme of “Breast and prostate cancer – more similar than different” with the view to leveraging similarities between these two cancers to develop new therapeutic targets and predictive biomarkers to improve disease outcomes.
Drs Theresa Hickey and Luke Selth co-present at the 7th PacRim Meeting
Dr Theresa Hickey and Dr Luke Selth jointly presented the opening address at the 7th PacRim International Breast & Prostate Cancer Meeting, Barossa Valley, SA, Australia. March 17, 2019. Opening presentation: "Breast and Prostate Cancer: more similar than different".
[Read more about Drs Theresa Hickey and Luke Selth co-present at the 7th PacRim Meeting]
Dr Theresa Hickey presents at the 7th International PacRim Meeting
Dr Theresa Hickey spoke in the session “Estrogen & androgen receptors: still key drivers?" at the 7th PacRim Breast & Prostate International Cancer Meeting, Barossa Valley, SA, Australia. March 17, 2019. Her talk’s title was "When is the androgen receptor oncogenic in breast cancer?"
[Read more about Dr Theresa Hickey presents at the 7th International PacRim Meeting]
Dr Theresa Hickey speaks at the inaugural Adelaide Cancer Research Symposium, BioMed City
Dr Theresa Hickey gave a presentation entitled "Targeting the androgen receptor in ER+ breast cancer" at the inaugural Adelaide Cancer Research Symposium, AHMS Building, BioMed City Precinct, Adelaide, SA, Australia. March 15, 2019.
Dr Theresa Hickey presents a seminar at IHBI in Brisbane
Dr Theresa Hickey presented some of her group’s research on "Androgenic suppression of estrogen-driven breast cancer" at the Translational Research Institute Seminar Series, Institute of Health and Biomedical Innovation, Brisbane, QLD, Australia. January 18, 2019.
[Read more about Dr Theresa Hickey presents a seminar at IHBI in Brisbane]
Dr Theresa Hickey presents at an International Congress on hormones in cancer
Dr Theresa Hickey presented at the 17th International Congress of Hormonal Steroids and Hormones & Cancer. Stellenbosch, South Africa. November 26-29, 2018. Her talk title was "Activation of the androgen receptor inhibits growth of estrogen receptor-driven breast cancer".
[Read more about Dr Theresa Hickey presents at an International Congress on hormones in cancer ]
